← FDA Drug Approvals (Drugs@FDA)

POTELIGEO

BLA · Biologics License Application · Sponsor: KYOWA KIRIN · Approved 2018-08-08

Drug application

FDA Application #
BLA761051
Application type
Biologics License Application
Brand name
POTELIGEO
Generic name
MOGAMULIZUMAB-KPKC
Active ingredients
MOGAMULIZUMAB-KPKC
Dosage form
INJECTABLE
Route
INJECTION
Marketing status
Prescription
Sponsor
KYOWA KIRIN
Manufacturer
Kyowa Kirin, Inc.
First approval
2018-08-08

Source

Authoritative
Drugs@FDA application overview
Machine
JSON-LD · Markdown